https://orcid.org/0000-0002-0247-9962
Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Luca Mastorino, Lorenza Burzi, Giada Frigatti, Alessandra Fazio, Valentina Celoria, Nicole Macagno, Francois Rosset, Stefania Ginevra Passerini, Gabriele Roccuzzo, Anna Verrone, Elena Stroppiana, Michela Ortoncelli, Paolo Dapavo, Pietro Quaglino & Simone Ribero. (2023) Clinical effectiveness of IL-17 and IL-23 inhibitors on difficult-to-treat psoriasis areas (scalp, genital, and palmoplantar sites): a retrospective, observational, single-center, real-life study. Expert Opinion on Biological Therapy 23:9, pages 929-936.
Read now
Read now
Chuanlan Gu & Junyi Yang. (2019) Risankizumab for the treatment of psoriasis. Expert Review of Clinical Pharmacology 12:9, pages 851-857.
Read now
Read now
Articles from other publishers (1)
Natalia Rompoti, Pelagia Katsimbri, Georgios Kokkalis, Dimitrios Boumpas, Ignatios Ikonomidis, Konstantinos Theodoropoulos, Dimitris Rigopoulos & Evangelia Papadavid. (2019) Real world data from the use of secukinumab in the treatment of moderate‐to‐severe psoriasis, including scalp and palmoplantar psoriasis: A 104‐week clinical study. Dermatologic Therapy 32:5.
Crossref
Crossref